[DPHARMA] YoY Annual (Unaudited) Result on 31-Dec-2016 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
YoY- -30.07%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 576,462 498,722 467,987 312,940 270,680 176,961 162,405 23.49%
PBT 70,809 59,666 51,796 31,479 49,755 46,509 40,175 9.90%
Tax -15,536 -12,025 -9,696 -4,653 0 0 -7,900 11.92%
NP 55,273 47,641 42,100 26,826 49,755 46,509 32,275 9.37%
-
NP to SH 55,273 47,641 42,492 27,115 38,775 35,271 32,275 9.37%
-
Tax Rate 21.94% 20.15% 18.72% 14.78% 0.00% 0.00% 19.66% -
Total Cost 521,189 451,081 425,887 286,114 220,925 130,452 130,130 26.00%
-
Net Worth 525,364 483,173 479,809 454,703 270,177 192,942 181,850 19.33%
Dividend
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Div 40,937 36,403 23,711 18,132 15,843 25,679 24,293 9.08%
Div Payout % 74.06% 76.41% 55.80% 66.87% 40.86% 72.81% 75.27% -
Equity
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Net Worth 525,364 483,173 479,809 454,703 270,177 192,942 181,850 19.33%
NOSH 684,383 661,881 278,959 278,959 278,959 138,807 138,817 30.44%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 9.59% 9.55% 9.00% 8.57% 18.38% 26.28% 19.87% -
ROE 10.52% 9.86% 8.86% 5.96% 14.35% 18.28% 17.75% -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
RPS 84.49 75.35 167.76 112.18 162.30 127.49 116.99 -5.27%
EPS 8.25 7.26 15.09 9.62 19.17 25.41 23.25 -15.85%
DPS 6.00 5.50 8.50 6.50 9.50 18.50 17.50 -16.33%
NAPS 0.77 0.73 1.72 1.63 1.62 1.39 1.31 -8.47%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
RPS 59.88 51.81 48.61 32.51 28.12 18.38 16.87 23.49%
EPS 5.74 4.95 4.41 2.82 4.03 3.66 3.35 9.38%
DPS 4.25 3.78 2.46 1.88 1.65 2.67 2.52 9.09%
NAPS 0.5457 0.5019 0.4984 0.4723 0.2807 0.2004 0.1889 19.33%
Price Multiplier on Financial Quarter End Date
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Date 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 -
Price 1.42 0.95 2.53 1.98 2.62 2.50 2.58 -
P/RPS 1.68 1.26 1.51 1.76 1.61 1.96 2.21 -4.46%
P/EPS 17.53 13.20 16.61 20.37 11.27 9.84 11.10 7.90%
EY 5.70 7.58 6.02 4.91 8.87 10.16 9.01 -7.34%
DY 4.23 5.79 3.36 3.28 3.63 7.40 6.78 -7.55%
P/NAPS 1.84 1.30 1.47 1.21 1.62 1.80 1.97 -1.13%
Price Multiplier on Announcement Date
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Date 13/02/20 18/02/19 28/02/18 24/02/17 23/02/16 24/02/15 26/02/14 -
Price 1.64 1.03 2.97 2.23 2.61 2.92 2.60 -
P/RPS 1.94 1.37 1.77 1.99 1.61 2.29 2.22 -2.22%
P/EPS 20.24 14.31 19.50 22.94 11.23 11.49 11.18 10.39%
EY 4.94 6.99 5.13 4.36 8.91 8.70 8.94 -9.40%
DY 3.66 5.34 2.86 2.91 3.64 6.34 6.73 -9.64%
P/NAPS 2.13 1.41 1.73 1.37 1.61 2.10 1.98 1.22%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment